Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech ranked by P/S ratio, at 1767, ahead of CRISPR Therapeutics (1156) and Kymera Therapeutics (263). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1767
Median
14.3
Combined market value
PLN 3.39T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1767PLN 28.7BPLN 321.81 1.25% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1156PLN 16.3BPLN 168.37 4.16% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care263PLN 41.6BPLN 487.12 0.44% down 87% up United States
4ImmunityBioIBRX · Health Care62.1PLN 28.3BPLN 26.61 5.59% up 193% up United States
5ModernaMRNA · Health Care41.9PLN 328.3BPLN 811.41 2.55% down 755% up United States
6Krystal BiotechKRYS · Health Care23.6PLN 37BPLN 1,248.35 3.86% up 46% up United States
7Twist BioscienceTWST · Health Care21.0PLN 31.8BPLN 466.03 3.35% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.5PLN 18.4BPLN 113.78 0.81% down 88% up United States
9RepligenRGEN · Health Care14.8PLN 44.1BPLN 689.56 5.60% up 5% up United States
10argenxARGX · Health Care14.3PLN 238.8BPLN 3,797.61 0.45% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4PLN 46BPLN 292.82 0.14% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.9PLN 44.6BPLN 390.96 1.18% up 37% up United States
13ExelixisEXEL · Health Care7.3PLN 67.9BPLN 278.45 0.96% up 63% up United States
14Gilead SciencesGILD · Health Care7.1PLN 846.2BPLN 682.21 0.48% down 33% up United States
15AmgenAMGN · Health Care6.6PLN 973.3BPLN 1,799.41 2.40% down 34% up United States
16BioNTechBNTX · Health Care6.5PLN 84BPLN 338.62 0.89% down 16% down Germany
17Neurocrine BiosciencesNBIX · Health Care5.8PLN 66.4BPLN 655.62 1.86% down 20% up United States
18QiagenQGEN · Health Care4.9PLN 41.2BPLN 199.48 0.41% down 12% up Netherlands
19BiogenBIIB · Health Care3.7PLN 148.7BPLN 1,006.26 0.34% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0262 PLN). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech rank first by P/S ratio?

CG Oncology (1767), CRISPR Therapeutics (1156) and Kymera Therapeutics (263) are the top three of the 19 biotech ranked by P/S ratio as of 18 Nov 2026, 16:31 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of PLN 3.39T as of 18 Nov 2026, 16:31 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.